(Q52515217)

English

Ivermectin in onchocerciasis.

scientific article published in December 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

Ivermectin in onchocerciasis. (English)

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

0 references

0 references

author name string

M A Aziz

1

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

S Diallo

2

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

M Lariviere

3

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

I M Diop

4

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

I M Porta

5

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

P Gaxotte

6

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

language of work or name

0 references

publication date

1 December 1982

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

2

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

1456-1457

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

8313

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

Efficacy and tolerance of ivermectin in human onchocerciasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991350-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and Laboratory changes Consequent to Diethylcarbamazine in Patients with Onchocerciasis *

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991350-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991350-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccine: efficacy in high-risk settings, a two-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991350-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991350-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(82)91350-2

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

1 reference

Europe PubMed Central

2 May 2018

http://europepmc.org/abstract/MED/6129524

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52515217&oldid=1399234365"